Multimodal visualization agents designed to enhance image-guided high-precision cancer therapy including surgery, radiotherapy, and chemotherapy
LINE安卓版不能用了
Learn how Nanovista’s proprietary technology illuminate tumors both at the planning stage and inside the operating room.
LINE安卓版不能用了
- Sector: Oncology/Image-guided interventions
- ip加速器破解 Multimodal imaging agent for cancer surgery and image-guided intervention
- Market Size: $2.7 Billion by 2023
- Development Stage: Pre-IND
LINE安卓版不能用了
Nanovista Team
Email: info@nanovista.com